Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Eye and Brain is Scopus-indexed (Q1, CiteScore 4.6), WoS ESCI, DOAJ. Published by Dove Medical Press Ltd.
Checked against the index lists dated .
ISSN 1179-2744Verify ISSN ↗
Publisher: Dove Medical Press Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Ophthalmology | 31 / 147 | 79th | Q1 |
| Sensory Systems | 17 / 43 | 61st | Q2 |
| Cellular and Molecular Neuroscience | 65 / 102 | 36th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2014–present, best quartile Q1, CiteScore 4.6.
Eye and Brain is Q1 in Ophthalmology (rank 31 of 147), Q2 in Sensory Systems (rank 17 of 43) and Q3 in Cellular and Molecular Neuroscience (rank 65 of 102), by CiteScore 2025.
Eye and Brain is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.6, which places it in quartile Q1 at the 79th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.790, quartile Q2, with an H-index of 33.
The publisher lists an article processing charge of about US$2,320 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Eye and Brain is published by Dove Medical Press Ltd. Its ISSN is 1179-2744.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Eye and Brain has an h-index of 40 and a 2-year mean of 3.88 citations per paper (OpenAlex). Its Scopus CiteScore is 4.6, quartile Q1. On 2-year citations it ranks #13 of 146 Scopus journals in Ophthalmology.
Eye and Brain published 13 papers in 2025; its busiest recent year was 2021 with 23. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 77 research articles (2021–2026), authors are most often from United States (37.4%), China (11%) and Canada (3.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.